Cyclo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.6%.

Top 25 shareholders own 53.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
31.5%	Rafael Holdings, Inc.	9,029,940	US$6.3m	0%	no data
5.23%	Armistice Capital LLC	1,501,625	US$1.1m	0%	0.03%
2.59%	N. Fine	743,804	US$521.2k	0%	no data
2.58%	EPIQ Capital Group, LLC	739,426	US$518.2k	-9.52%	0.14%
2.09%	The Vanguard Group, Inc.	598,694	US$419.5k	34.1%	no data
2.06%	The Founders Fund, LLC	590,731	US$414.0k	0%	11.23%
1.33%	Markus Sieger	382,122	US$267.8k	10.1%	no data
1.29%	C. Strattan	369,103	US$258.7k	20.8%	no data
1.22%	F. Ostronic	348,771	US$244.4k	0%	no data
0.53%	Geode Capital Management, LLC	152,332	US$106.7k	-13.2%	no data
0.52%	William Shanahan	148,826	US$104.3k	11.3%	no data
0.51%	Randall Toig	145,826	US$102.2k	16%	no data
0.38%	Shawn Cross	107,749	US$75.5k	19%	no data
0.32%	Jeffrey Tate	92,042	US$64.5k	0%	no data
0.29%	BlackRock, Inc.	83,521	US$58.5k	40.4%	no data
0.18%	William Conkling	50,230	US$35.2k	49.6%	no data
0.14%	Vivien Wong	39,713	US$27.8k	61.7%	no data
0.14%	State Street Global Advisors, Inc.	39,530	US$27.7k	0%	no data
0.082%	Wealth Enhancement Advisory Services, LLC	23,400	US$16.4k	14.7%	no data
0.076%	Northern Trust Global Investments	21,722	US$15.2k	0%	no data
0.059%	Joshua Fine	16,900	US$11.8k	0%	no data
0.043%	UBS Asset Management AG	12,458	US$8.7k	3.36%	no data
0.043%	Michael Lisjak	12,400	US$8.7k	0%	no data
0.022%	The First Bridge University, Incorporated	6,307	US$4.4k	0%	no data
0.019%	Tower Research Capital Europe Limited	5,395	US$3.8k	7.92%	no data